Peptide record

TPDB09620

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09620
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLFTLIKGAYKLDAPTVACN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C96H155N23O27S1
REQHMSW
AL
2095.48
8.86
2
1
10
+1
-0.18
0.545
107.50
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
0.71
5
Residue Composition
number
3
A
0
R
1
N
1
D
1
C
0
E
0
Q
2
G
0
H
1
I
3
L
2
K
0
M
1
F
1
P
0
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 1 D: 1 C: 1 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 3 K: 2 M: 0 F: 1 P: 1 S: 0 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
20 reviewed residue count
C96H155N23O27S1 sequence-only estimate (linear, free termini)
2095.48 sequence-only estimate (linear, free termini)
8.86 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.18 sequence-only estimate (linear, free termini)
0.545 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
40.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 2 Activity

Activity

MIC
Antibacterial
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
20.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
40.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 5 Activity

Activity

MIC
Antifungal
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
20.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
40.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 8 Activity

Activity

MIC
Antiparasitic
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
20.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
40.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 11 Activity

Activity

MIC
Antiviral
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
20.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021